5
Linear Accelerators for Radiation Market
Linear Accelerators for Radiation Market Restraints
Major concerns of affordability and accessibility for the treatment, lack of trained personnel to operate linear accelerators, are some of the limiting factors, which may hinder the future market growth for linear accelerators for radiation.
Linear Accelerators for Radiation Market – Regional Analysis
Geographically, global linear accelerators for radiation market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. Growing adoption of linear accelerators by prominent cancer treatment centers, worldwide; and upgrading the conventional treatment, will augment growth of the linear accelerators for radiation market, in the near future. In May 2016, Leeds Cancer Centre, a leading providers of cancer care in the U.K. updated its existing treatment equipment with eight Elekta Versa HD linear accelerators. The Versa HD linear accelerators combined with Volumetric Arc Therapy (VMAT) allows to deliver complex head and neck cancer therapy up to 42% faster. Furthermore, in November 2017, Romanian government signed for five Elekta linear accelerators, to supply the country with sophisticated radiation therapy devices. In addition, Princess Margaret Cancer Centre from Canada and Odense University Hospital from Denmark in December 2016, also ordered high-field MR-supported linear accelerator (MR-linac). Both Versa HD linear accelerator and high-field MR-supported linear accelerator (MR-linac) are manufactured by Elekta AB.